6WW8 | pdb_00006ww8

BRD4 Bromodomain 1 in complex with triple CDK4/6-PI3K-BET inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.235 (Depositor), 0.240 (DCC) 
  • R-Value Work: 
    0.193 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 
    0.197 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 6WW8

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.

Burgoyne, A.M.Vann, K.R.Joshi, S.Morales, G.A.Vega, F.M.Singh, A.Pal, D.Merati, A.B.Kutateladze, T.G.Durden, D.L.

(2020) Cell Discov 6: 49-49

  • DOI: https://doi.org/10.1038/s41421-020-0181-z
  • Primary Citation Related Structures: 
    6WW8

  • Organizational Affiliation
    • Division of Hematology-Oncology, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA USA.

Macromolecule Content 

  • Total Structure Weight: 16.85 kDa 
  • Atom Count: 1,177 
  • Modeled Residue Count: 131 
  • Deposited Residue Count: 138 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Bromodomain-containing protein 4138Homo sapiensMutation(s): 0 
Gene Names: BRD4HUNK1
UniProt & NIH Common Fund Data Resources
Find proteins for O60885 (Homo sapiens)
Explore O60885 
Go to UniProtKB:  O60885
PHAROS:  O60885
GTEx:  ENSG00000141867 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60885
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
YR0
(Subject of Investigation/LOI)

Query on YR0



Download:Ideal Coordinates CCD File
B [auth A]7-cyclopentyl-N,N-dimethyl-2-({4-[5-(morpholin-4-yl)-7-oxo-7H-thieno[3,2-b]pyran-3-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
C31 H32 N6 O4 S
XJKTXWSMMWPNTP-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.235 (Depositor), 0.240 (DCC) 
  • R-Value Work:  0.193 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 0.197 (Depositor) 
Space Group: P 31
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 45.318α = 90
b = 45.318β = 90
c = 61.895γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data reduction
HKL-3000data scaling
PHASERphasing
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Cancer Institute (NIH/NCI)United States--

Revision History  (Full details and data files)

  • Version 1.0: 2020-08-26
    Type: Initial release
  • Version 1.1: 2023-10-18
    Changes: Data collection, Database references, Refinement description